Photo Credit: ThinkStock

Exclusive: Mankind Pharma reviews strategy; begins prep work for IPO

25 November, 2016

Capital International-backed Mankind Pharma Ltd, which had previously said it would not look at an initial public offering before 2020, is relooking at its plan and has started preliminary work to go public, a top company executive told VCCircle.


Leave Your Comment
Exclusive: Drug maker Alkem Laboratories picks three bankers for its mega IPO

Exclusive: Drug maker Alkem Laboratories picks three bankers for its mega IPO

Jasleen Kaur Batra 2 years ago
Alkem Laboratories Ltd, a generic and specialty drug manufacturer which has been considering going public, has finalised its bankers for the initial public offer (IPO),...
ChrysCapital to score multi-bagger exit via Eris Lifesciences IPO

ChrysCapital to score multi-bagger exit via Eris Lifesciences IPO

Joseph Rai and Ankit Doshi 2 months ago
Private equity firm ChrysCapital Investment Advisors India Pvt. Ltd is set to walk away with a bountiful harvest from its almost six-year-old investment in drugmaker...
Mankind Pharma picks industry veteran for diagnostics biz float

Mankind Pharma picks industry veteran for diagnostics biz float

Joseph Rai 6 months ago
Drugmaker Mankind Pharma Ltd is entering the diagnostics business and has picked a prominent industry veteran to spearhead the venture, two persons privy to the...
No Comments

Exclusive: Mankind Pharma reviews strategy; begins prep work for IPO

Powered by WordPress.com VIP